Affiliation:
1. Oriola, Espoo, Finland
2. Camurus AB, Lund, Sweden
3. Kuopio Addiction Medicine Center, Kuopio, Finland
Abstract
Aims: To characterise and understand the untreated high-risk opioid user population in Finland, and to determine the reasons why these people do not enter treatment. Methods: The study setting was a half-year cross-sectional survey in Finland during 2021–2022. An electronic questionnaire with 24 structured questions was concluded in 16 needle exchange units. Participants were opioid-dependent people without opioid agonist treatment (OAT), and they answered the survey voluntarily and anonymously. Results: Of the 167 respondents, 62% were men, 53% were aged ≤34 years, 66% had used opioids for >6 years, and 78% used drugs intravenously (IV) daily. The most used opioid (95%) was buprenorphine. Most respondents used opioids as self-medication for withdrawal symptoms (75%), or to treat psychological symptoms (59%) or pain (43%). Of them, 70% also used other substances for recreational purposes. The most common named reasons to stay outside OAT were as follows: seeking treatment is too difficult (37%); treatment is too binding (36%); and fear of actions from authorities (23%). Conclusions: For opioid-dependent respondents who would be eligible for OAT in Finland, treatment awareness is limited. These high-risk opioid users also think that the treatment would be too binding. In conclusion, there is a need for increase in general information about, accessibility to, acceptance for and individualisation of OAT.
Subject
Health Policy,Health (social science)
Reference25 articles.
1. The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users
2. A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction
3. EMCDDA, European Monitoring Centre for Drugs and Drug Addiction (2021). European Drug Report – Trends and Developments 2021. Available at https://www.emcdda.europa.eu/system/files/publications/13838/TDAT21001ENN.pdf (Accessed Oct 13, 2022).
4. EMCDDA, European Monitoring Centre for Drugs and Drug Addiction (2022). European Drug Report – Trends and Developments 2022. Available at https://www.emcdda.europa.eu/system/files/publications/14644/TDAT22001ENN.pdf (Accessed Oct 13, 2022).
5. Finlex 386/2011 (2011). Ajokorttilaki [Driving Licence Act]. Available at https://www.finlex.fi/fi/laki/ajantasa/2011/20110386 [In Finnish] (Accessed Jun 06, 2023).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Snow season: The normalisation of cocaine;Nordic Studies on Alcohol and Drugs;2024-03-18